LTBR identified as potential target for cancer immunotherapy and marker of poor prognosis

A new research paper was published in Aging (listed by MEDLINE/PubMed as “Aging (Albany NY)” and “Aging-US” by Web of Science) Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.”

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update – Biotech Investments

Issuer: Immunic AG / Key word(s): Quarter Results/Quarterly / Interim Statement 08.05.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this

May 9, 2024

Remote strategy-based intervention shows promise for individuals with memory impairments caused by MS

A pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS).

June 28, 2024

Breakthrough in the synthesis of fungal bioactive compounds for therapeutic applications

The natural world is rich in chemical compounds with remarkable medicinal properties. A notable example is penicillin, discovered by chance from the Penicillium mold.

August 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.